A financier has been selected to head California’s public stem cell research agency.
A financier has been selected to head California’s
public stem cell
research agency. The board of the California Institute for Regenerative
Medicine selected its next chairman, Jonathan Thomas, by a vote of 14 to 11.
Thomas, an investment banker, will succeed longtime chairman Robert Klein.
Klein’s reign as chairman has been rife with controversy due to his hands-on
approach at the agency, which led to high turnover among the agency’s chief
executives. Klein had planned to resign late last year, but agreed to stay on
for another six months when his candidate withdrew from the pool amid
accusations of backroom deals. Thomas narrowly won the majority of the board’s
votes. ~ San Francisco
Examiner, Jun 23
Financier Jonathan Thomas selected to lead California stem cell agency
stem cell research
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012